Business Combinations and Asset Purchases (Tables)

12 Months Ended

Dec. 31, 2017

Business Acquisition, Pro Forma Information [Table Text Block]

The following unaudited pro forma information presents the combined financial results for the Company and EUROIMMUN as if the acquisition of EUROIMMUN had been completed at the beginning of fiscal year 2016:



	December 31, 2017		January 1, 2017
	(In thousands, except per share data)
Pro Forma Statement of Operations Information (Unaudited):
Revenue	$	2,562,580	$	2,379,176
Income from continuing operations	143,459		156,210
Basic earnings per share:
Income from continuing operations	$	1.31	$	1.43
Diluted earnings per share:
Income from continuing operations	$	1.29	$	1.42

Fair Values of the Business Combinations and Allocations for the Acquisitions Completed

The total purchase price for the acquisitions in fiscal year 2016 has been allocated to the estimated fair values of assets acquired and liabilities assumed as follows:



	2016 Acquisitions
	(In thousands)
Fair value of business combination:
Cash payments	$	72,497
Working capital and other adjustments	(261		)
Less: cash acquired	(2,152		)
Total	$	70,084
Identifiable assets acquired and liabilities assumed:
Current assets	$	7,153
Property, plant and equipment	7,542
Identifiable intangible assets:
Core technology	6,600
Trade names	570
Customer relationships	14,900
Goodwill	43,072
Deferred taxes	(7,768		)
Liabilities assumed	(1,985		)
Total	$	70,084

The total purchase price for the acquisitions in fiscal year 2015 has been allocated to the estimated fair values of assets acquired and liabilities assumed as follows:



	2015 Acquisitions
	(In thousands)
Fair value of business combination:
Cash payments	$	75,285
Contingent consideration	56,878
Working capital and other adjustments	1,832
Less: cash acquired	(3,864		)
Total	$	130,131
Identifiable assets acquired and liabilities assumed:
Current assets	$	2,551
Property, plant and equipment	998
Identifiable intangible assets:
Core technology	15,759
Trade names	200
Licenses	116
Customer relationships	3,073
IPR&D	75,700
Goodwill	53,112
Deferred taxes	(18,528		)
Liabilities assumed	(2,850		)
Total	$	130,131

The total purchase price for the acquisitions in fiscal year 2017 have been allocated to the estimated fair values of assets acquired and liabilities assumed as follows:



	EUROIMMUN			2017 Other
	(In thousands)
Fair value of business combination:
Cash payments	$	1,413,780		$	140,861
Other liability	—			1,273
Less: cash acquired	(25,018		)	(2,439		)
Total	$	1,388,762		$	139,695
Identifiable assets acquired and liabilities assumed:
Current assets	$	121,174		$	16,268
Property, plant and equipment	129,964			11,356
Other assets	49,944			1,691
Identifiable intangible assets:
Core technology	160,000			12,400
Trade names	36,000			3,000
Customer relationships	700,000			43,700
In-process research and development ("IPR&D")	1,400			—
Goodwill	614,759			75,453
Deferred taxes	(275,491		)	(15,414		)
Liabilities assumed	(87,631		)	(8,759		)
Debt assumed	(61,357		)	—
Total	$	1,388,762		$	139,695